NCT05608655 (DELTA) is a NA clinical trial of DKutting LL balloon in Femoral Artery Stenosis, sponsored by DK Medical Technology (Suzhou) Co., Ltd..

Who is sponsoring NCT05608655?

NCT05608655 is sponsored by DK Medical Technology (Suzhou) Co., Ltd..

What drugs are being tested in NCT05608655?

Interventions in NCT05608655: DKutting LL balloon, Chocolate balloon.

What condition does NCT05608655 study?

NCT05608655 studies Femoral Artery Stenosis, Popliteal Artery Stenosis.

Is NCT05608655 still recruiting?

NCT05608655 is currently completed. Last updated 20 February 2024.

Last reviewed 2024-02-20 · How we verify

NCT05608655: DELTA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DKutting Balloon Versus Chocolate Balloon to Treat Femoral and Popliteal Artery Stenosis

Completed NA Last updated 20 February 2024

What this trial tests

NA trial testing DKutting LL balloon in Femoral Artery Stenosis in 188 participants. Completed in 4 February 2024.

Timeline

27 December 2022

Primary endpoint
10 January 2024

4 February 2024

Quick facts

Lead sponsor	DK Medical Technology (Suzhou) Co., Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	188
Start date	27 December 2022
Primary completion	10 January 2024
Estimated completion	4 February 2024
Sites	14 locations across China

Drugs / interventions tested

DKutting LL balloon
Chocolate balloon

Conditions studied

Femoral Artery Stenosis — all drugs for Femoral Artery Stenosis →
Popliteal Artery Stenosis — all drugs for Popliteal Artery Stenosis →

Sponsor

DK Medical Technology (Suzhou) Co., Ltd.

Who can join

Adults 18 to 80, any sex, with Femoral Artery Stenosis or Popliteal Artery Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy and Safety of DKutting Balloon Versus Chocolate Balloon in the Treatment of Femoral and Popliteal Artery Stenosis

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other DK Medical Technology (Suzhou) Co., Ltd. trials

Trials by the same sponsor.

NCT05250193 — DK Score Coronary Scoring Balloon: a RCT Trial to Evaluate Acute Lumen Gain (SCORE CHINA) · NA · completed
NCT04226599 — A Safety and Efficacy Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With DissolveAV · NA · completed
NCT03376646 — A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease · NA · completed
NCT03373695 — A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05608655 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by DK Medical Technology (Suzhou) Co., Ltd.
Last refreshed: 20 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05608655.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing